| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/23/2009 | US20090105183 Pharmaceutical composition containing decoy and method of using the same |
| 04/23/2009 | US20090105180 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 04/23/2009 | US20090105177 Modulation of diacylglycerol acyltransferase 1 expression |
| 04/23/2009 | US20090105160 Pharmaceutical composition, package and method for rapidly reducing the uric acid in blood |
| 04/23/2009 | US20090105159 Neuroprotective Compounds and Uses Thereof |
| 04/23/2009 | US20090105158 Peptide substance revealing a stress protective effect, pharmaceutical composition on its base, and the method of its application |
| 04/23/2009 | US20090105157 Peptide substance stimulating regeneration of central nervous system neurons, pharmaceutical composition on its base, and the method of its application |
| 04/23/2009 | US20090105156 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/23/2009 | US20090105155 Truncated lhrh formulations |
| 04/23/2009 | US20090105154 promotes regeneration of tissue, decreased apoptosis of stem cells |
| 04/23/2009 | US20090105153 Gonadotropin Releasing Hormone Antagonists |
| 04/23/2009 | US20090105152 Metastin derivatives and use thereof |
| 04/23/2009 | US20090105151 Amphipathic alpha-helical peptide compositions as antiviral agents |
| 04/23/2009 | US20090105150 Angiotensin derivatives |
| 04/23/2009 | US20090105149 Compounds comprising lpa |
| 04/23/2009 | US20090105148 Compositions and methods for treating myocardial infarction |
| 04/23/2009 | US20090105147 Deuterated etravirine |
| 04/23/2009 | US20090105146 Proteins, nucleic acids and medicaments |
| 04/23/2009 | US20090105145 Method of Diagnosing and Treating Colon Cancer |
| 04/23/2009 | US20090105144 One-component bone cement pastes and methods for curing them |
| 04/23/2009 | US20090105142 Treatment with kallikrein inhibitors |
| 04/23/2009 | US20090105141 Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 04/23/2009 | US20090105140 Albumin Fusion Proteins |
| 04/23/2009 | US20090105139 Soluble HER2 and HER3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease |
| 04/23/2009 | US20090105138 Methods for treating immune mediated neurological diseases |
| 04/23/2009 | US20090105137 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/23/2009 | US20090105136 NPY Y2 Agonist for Use as Therapeutic Agent for Disease Accompanied by Diarrhea |
| 04/23/2009 | US20090105135 Therapeutic Agent for Cancer |
| 04/23/2009 | US20090105134 C-Terminally Pegylated Growth Hormones |
| 04/23/2009 | US20090105133 Gamma-Delta T Cell Receptors |
| 04/23/2009 | US20090105132 Method for Enchancing Cyclodextrin Complexation |
| 04/23/2009 | US20090105131 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 04/23/2009 | US20090105130 Depsipeptide-containing injection solution |
| 04/23/2009 | US20090105129 Combination therapy |
| 04/23/2009 | US20090105128 Cannabinoid receptor targeted agent |
| 04/23/2009 | US20090105127 Methods for stabilizing corneal tissue |
| 04/23/2009 | US20090105126 Methods of Treating Pulmonary Disorders using Liposomal Vancomycin Formulations |
| 04/23/2009 | US20090105125 Methods of Treating Fatty Liver Disease |
| 04/23/2009 | US20090105124 Heterocyclic modulators of tgr5 |
| 04/23/2009 | US20090105123 Methods for the treatment of muscle loss |
| 04/23/2009 | US20090105122 Selective neuropeptide y2 receptor agonists |
| 04/23/2009 | US20090105121 Insulin Derivative |
| 04/23/2009 | US20090105120 Method for preparing tryptophan rich peptides |
| 04/23/2009 | US20090105119 Asparagine-10-substituted nonadepsipeptides |
| 04/23/2009 | US20090105118 Preparation and applications of novel complexes made by gamma-polyglutamic acid and cisplatin |
| 04/23/2009 | US20090105117 Stem cells and lim mineralization proteins |
| 04/23/2009 | US20090105116 Polypeptide Ligands Containing Linkers |
| 04/23/2009 | US20090105115 Polyamides for nucleic acid delivery |
| 04/23/2009 | US20090105086 Methods of selecting internalizing antibodies |
| 04/23/2009 | US20090104684 Diagnosis of carcinomas |
| 04/23/2009 | US20090104662 Use of interleukin-4 antagonists and compositions thereof |
| 04/23/2009 | US20090104661 Human Coagulation Factor VII Polypeptides |
| 04/23/2009 | US20090104631 Psca: prostate stem cell antigen and uses thereof |
| 04/23/2009 | US20090104279 Use of pak inhibitor for the treatment of a joint disease |
| 04/23/2009 | US20090104275 Nanoencapsulation of Proteins |
| 04/23/2009 | US20090104273 Novel nifedipine compositions |
| 04/23/2009 | US20090104260 Compositions and methods for sirna inhibition of icam-1 |
| 04/23/2009 | US20090104259 Compositions and methods for sirna inhibition of angiogenesis |
| 04/23/2009 | US20090104257 Liposomal Vancomycin Formulations |
| 04/23/2009 | US20090104249 Exotoxin Inhibitory Factor |
| 04/23/2009 | US20090104244 Therapeutic agent-eluting medical devices having textured polymeric surfaces |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | US20090104218 Group B Streptococcus |
| 04/23/2009 | US20090104216 Peptide-Based Influenza Vaccine Formulation |
| 04/23/2009 | US20090104214 Synthetic peptides containing the motif "YWWLXP" as anthrax toxin antidotes |
| 04/23/2009 | US20090104212 Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption |
| 04/23/2009 | US20090104211 Treatment of atherosclerosis |
| 04/23/2009 | US20090104210 Peptide compounds for treating obesity and insulin resistance |
| 04/23/2009 | US20090104209 Methods of reducing a viral infection and kits therefore |
| 04/23/2009 | US20090104208 House Dust Mite Allergen |
| 04/23/2009 | US20090104206 Bone microenvironment modulated migraine treatments |
| 04/23/2009 | US20090104205 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus |
| 04/23/2009 | US20090104199 Breast Cancer Resistance Protein (BCRP) And The DNA Which Encodes It |
| 04/23/2009 | US20090104198 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 04/23/2009 | US20090104197 vWFA and/or ANT_IG Domain Containing Proteins |
| 04/23/2009 | US20090104195 Targeted ligands |
| 04/23/2009 | US20090104193 SEMA4D in Cancer Diagnosis, Detection and Treatment |
| 04/23/2009 | US20090104191 Prevention of tumors with monoclonal antibodies against neu |
| 04/23/2009 | US20090104189 Neutrokine-alpha and neutrokine-alpha splice variant |
| 04/23/2009 | US20090104183 Glue composition for lung volume reduction |
| 04/23/2009 | US20090104180 Using selectin/immunoglobulin fusion for quelling organ transplant rejection |
| 04/23/2009 | US20090104178 Chemokine binding activity of viral tnf receptors and related proteins |
| 04/23/2009 | US20090104177 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| 04/23/2009 | US20090104176 Exhibit altered chondroitin lyase activity or increased resistance to inactivation from stressors including exposure to ultraviolet radiation or heat; administered following a contusion or spinal cord injury to the central nervous system |
| 04/23/2009 | US20090104175 Use of caspases for the preparation of medicaments |
| 04/23/2009 | US20090104174 Methods and compositions for reducing the appearance of dynamic facial wrinkles |
| 04/23/2009 | US20090104173 Novel process for solubilizing protein from a proteinaceous material and compositions thereof |
| 04/23/2009 | US20090104166 Stimulating neurite outgrowth using tctex-1-related polypeptides |
| 04/23/2009 | US20090104154 Composition and method for killing of tumours |
| 04/23/2009 | US20090104152 Glycosylated interferon alpha |
| 04/23/2009 | US20090104151 Smac mimetic dimers and trimers useful as anti-cancer agents |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | US20090104149 Compositions For HCV Treatment |
| 04/23/2009 | US20090104148 Treatment and prevention of joint disease |
| 04/23/2009 | US20090104147 Sialoadhesin-Related Compositions and Methods |
| 04/23/2009 | US20090104146 Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing osmrbeta as a subunit, and applications thereof |
| 04/23/2009 | US20090104142 Compositions for treating multiple sclerosis |
| 04/23/2009 | US20090104121 Multi-subunit biological complexes for treatment of plaque-associated diseases |
| 04/23/2009 | US20090104119 Dendrimer Based Compositions And Methods Of Using The Same |
| 04/23/2009 | US20090104117 Compositions and methods of use of targeting peptides against placenta and adipose tissues |